Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medbright AI Investments Inc C.MBAI

Alternate Symbol(s):  MBAIF

MedBright AI Investments Inc. is a capital allocator focused on investing in healthcare technology companies. The Company is engaged in constructing a portfolio of synergistic investments to generate returns for shareholders. The Company is focused on significant near-term and midterm opportunities with potential returns while maintaining a commitment to governance. It is focused on investing in technology and artificial intelligence companies, combined with healthcare operators.


CSE:MBAI - Post by User

Post by 1StockInformeron Jan 18, 2024 4:35pm
44 Views
Post# 35834664

News: >$100M in Clinic Rev Under Contract with MedMatrix

News: >$100M in Clinic Rev Under Contract with MedMatrix

Today, MedBright AI Investments Inc. (MBAI.c or MBAIF for US investors) announced the achievement of its near-term goal, reaching a significant milestone in total clinic revenue under contract with MedMatrix, MBAI's cutting-edge AI-powered data analytics platform.


With 14 clinics now using MedMatrix across the United States and Canada, MBAI has successfully facilitated an estimated US$100M in total clinic revenue. This accomplishment marks a momentous stride in the Company's strategic partnership with MedMatrix, illustrating the impactful integration of AI in healthcare management.


"The adoption of MedMatrix has been extraordinary, with multiple clinic groups signing on in just two short months," stated Dr. Jaime Gerber, Chairman of MedBright AI. "We look forward to continued expansion to many more clinic groups and continuing our rapid growth trajectory."


MBAI, as the primary shareholder in MedMatrix, underscores its commitment to leveraging artificial intelligence for healthcare advancement. 


MedMatrix utilizes AI to assess critical aspects of healthcare facilities, including patient needs, revenue cycle management, patient demographics, facility geography, and competition. 


By optimizing these key areas through advanced AI and data analytics, MedMatrix collaborates with healthcare professionals to enhance clinic operations and elevate patient outcomes.


Full news here: https://financialpost.com/globe-newswire/medbright-ai-reaches-us100m-in-total-clinic-revenue-under-contract-with-medmatrix-the-ai-powered-data-analytics-platform


Posted on behalf of Medbright AI Investments Inc.

 
<< Previous
Bullboard Posts
Next >>